The shares of Johnson & Johnson (NYSE:JNJ) has been pegged with a rating of Outperform by Credit Suisse in its latest research note that was published on July 12th, 2019. The research company has also assigned a $156 price target. Credit Suisse wasn’t the only research firm that published a report of Johnson & Johnson, with other equities research analysts also giving their opinion on the stock. Goldman advised investors in its research note published on May 28th, 2019, to Buy the JNJ stock. The stock had earned Equal Weight rating from Barclays when it published its report on January 23rd, 2019. That day the Barclays set price target on the stock to $135. The stock was given Neutral rating by Goldman in its report released on July 12th, 2018. Bernstein was of a view that JNJ is Mkt Perform in its latest report on June 27th, 2018 while giving it a price target of $129. Citigroup thinks that JNJ is worth Neutral rating. This was contained in the firm’s report on April 23rd, 2018 in which the stock’s price target was also moved to $134.
The consensus currently stands at a Hold while its average price target is $149.00. The price of the stock the last time has raised by 10.26% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 51.64.
The shares of the company added by 1.13% during the trading session on Tuesday, reaching a low of $132.00 while ending the day at $133.42. During the trading session, a total of 5.02 million shares were traded which represents a 32.68% incline from the average session volume which is 7.45M shares. JNJ had ended its last session trading at 131.93. Johnson & Johnson currently has a market cap of $353.90B, while its P/E ratio stands at 22.13, while its P/E earnings growth sits at 4.35, with a beta of 0.68. Johnson & Johnson debt-to-equity ratio currently stands at 0.48, while its quick ratio hovers at 1.00. JNJ 52-week low price stands at $121.00 while its 52-week high price is $148.99.
Johnson & Johnson has the potential to record 6.03 EPS for the current fiscal year, according to equities analysts.
Investment analysts at MKM Partners published a research note on May 28th, 2019 where it informed investors and clients that Hess Corporation (NYSE:HES) is now rated as Buy. Goldman also rated HES as Initiated on May 28th, 2019, with its price target of $85 suggesting that HES could surge by 13.33% from its current share price. Even though the stock has been trading at $60.81/share, analysts expect it to surge higher by 1.99% to reach $71.56/share. It started the day trading at $62.76 and traded between $59.97 and $62.02 throughout the trading session.
A look at its technical shows that HES’s 50-day SMA is 60.50 while its 200-day SMA stands at 57.65. At the moment, only of Hess Corporation shares were sold short. The company’s average trading volume currently stands at 2.93M shares, which means that the short-interest ratio is just 3.97 days. Over the past seven days, the company moved, with its shift of 7.86%. Looking further, the stock has dropped -3.37% over the past 90 days while it gained 12.48% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. Fidelity Management Research Co bought more HES shares, increasing its portfolio by +64.98% during the last quarter. This move now sees Fidelity Management Research Co purchasing 11,641,701 shares in the last quarter, thus it now holds 29,557,176 shares of HES, with a total valuation of $1,916,487,292. The Vanguard Group Inc meanwhile sold more HES shares in the recently filed quarter, changing its stake to $1,887,286,857 worth of shares.
Similarly, SSgA Funds Management Inc decreased its Hess Corporation shares by -0.72% during the recently filed quarter. After selling -94,992 shares in the last quarter, the firm now controls 13,034,526 shares of Hess Corporation which are valued at $845,158,666. In the same vein, Wellington Management Co LLP decreased its Hess Corporation shares by during the most recent reported quarter. The firm sold -883,515 shares during the quarter which decreased its stakes to 12,765,722 shares and is now valued at $827,729,414. Following these latest developments, around 0.30% of Hess Corporation stocks are owned by institutional investors and hedge funds.